The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
William C. Powell(Vanderbilt University), Lynn M. Matrisian(Pancreatic Cancer Action Network), Mark Boothby(Vanderbilt University), Barbara Fingleton(Vanderbilt University), Carole L. Wilson(University of Wisconsin–Madison)
Cited by 422
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The matrix‐degrading metalloproteinases
|BioEssays|1992|1.4k